Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Womens Health Asia Pacific 2018

About Conference


International Conference on Women's Health and Breast Cancer (Women’s Health Asia Pacific 2018) extends its welcome to you during November 19-20, 2018 at Sydney, Australia with a theme ''Challenges in targeting Cancer and its Therapeutic Advances and Wellness of Women''.

Conference Series LLC Ltd Organises 1000+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.  

Breast Cancer can impact the total being of a Woman, different phases of threat, reason of the infection, degeneration of cells, safe framework issue, and even loss of complete wellbeing and prosperity. The pioneers in the research field and their exploration works are the major features of the gathering.

The conference invites Breast Cancer SurgeonsWomen Health care professionalsPathologistsOncologists, Researchers, Students, Young researchers and business delegates across the globe.

Why to Attend?

Women's Health 2018 is the fundamental event that joins a fascinating and all inclusive pro, examiners and pioneers both from the academic group and industry over the world to exchange their knowledge, aptitude and research advancements in the field of tumor treatment. In the midst of the segment of the two-day gathering, you can profit opportunity to both framework and see pioneers from the overall educational and corporate development investigate gatherings.

The fundamental accentuation will be on viewpoints, for example, Cancer Basic and Applied Researches, Women's Health care, Organ Specific Cancers, Advances in Treatment Approaches, Anti-Cancer Therapies, Breast Cancer Diagnosis, Treatment trough Precision Medicine, Novel Treatment Procedures, Entrepreneurs Meetings and so forth.

 

Scientific Sessions

Track 1: Biology of Breast Cancer

Breast Cancer is the most widely recognized reason for death in ladies. We first need to see how disease creates in the body for diminishing bosom tumor hazard. What is disease and how it creates can enable us to discover approaches to back off its encouraging or maybe prevent it from happening in any case. Ebb and flow comprehension of the science of bosom tumor is essential and its pertinence to treating and keeping the illness. Bosom malignancy is definitely not a one infection. For instance, understanding that bosom tissue of young ladies and young ladies is particularly delicate to disease causing operators can help guide hazard diminishment endeavors to these gatherings. Understanding growth signifies stepping toward more advised choices about our bodies, ourselves and our condition.

Related Conferences35th Annual Miami Breast Cancer Conference March 8-11, 2018, Fontainebleau Miami Beach,7th World Congress Breast Cancer May 10-11,2018 Frankfurt, Germany,8th World Congress Breast Cancer & Therapies, July 16-17,2018 Melbourne,Australia,7th World Congress on Breast Cancer Mat 25-26,2018,Radissson Hotel Fairport New York,USA,World Congress On Breast Cancer ,London,UK,June11,13,2018, Thriving Together: 2018 Conference on Metastatic Breast Cancer, April 20,2018,2nd  International Conference on Women Health And Breast Cancer, May 24-25, 2018 at Valencia, Spain, 3rd Global Insight Conference on Breast Cancer Jul 16 - 18, 2018, Valencia, Spain, The 28th Annual Interdisciplinary Breast Center ConferenceThe 28th Annual Interdisciplinary Breast Center Conference, 2018 Conference March 9-14, Paris Las Vegas, International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2018 San Diego, California, USA, Cancer Genetics Course 2018, 29 Jan 2017 - 01 Feb 2018 • London, United Kingdom.

Track 2: Screening, Detecting and Diagnosing Breast Cancer

Mammography is one of the most common screening test for breast cancer. A diagnostic mammogram is used to find breast disease in women who have breast symptoms or an abnormal result on a screening mammogram. Screening mammograms are used to look for breast disease in women who are asymptomatic; that is, those who appear to have no breast problems. The other types of screening and diagnostic tests are Biopsy, Sentinel node biopsy, Breast MRI and Breast Ultrasound.

The objective of screening exams for bosom malignancy is to distinguish tumors before they begin to bring on any side effects. Early identification implies utilizing an approach or test that lets bosom disease get analyzed sooner than generally may have happened. Finding out about Screening Tests and Diagnostic Tools for bosom disease is imperative to slaughter the bosom malignancy in beginning times. There are various approaches to check for bosom growth. A few tests are fundamental; some are more intrusive yet give more data. Be that as it may, all are essential to help recognize this bosom malignancy sickness in right on time.

The Breast Cancer Society of Canada, Canada; American Cancer Society, USA; National Breast Cancer Foundation (NBCF) Australia; New Zealand Breast Cancer Foundation, New Zealand; European Society for Medical Oncology , EUSOMA - European Society of Breast Cancer Specialists, Italy; The Breast Cancer Research Foundation, USA; Japanese Breast Cancer Society, Japan; Irish Cancer Society, Ireland; Austrian Cancer Society, Austria, German Cancer Society, Germany; Swedish Cancer Society, Sweden; UK Oncology Nursing Society, UK; Naturopathic Cancer Society, USA

Track 3: Breast Cancer Risk and Cause

Every woman needs to perceive what she can do to bring down her peril of Breast malady. A segment of the segments associated with bosom ailment - being a woman, your age, and your inherited characteristics, for example - can't be changed. Distinctive factors - being overweight, nonappearance of work out, smoking cigarettes, and eating unwanted sustenance - can be changed by settling on choices. By picking the most useful lifestyle decisions possible, you can empower yourself and guarantee your bosom ailment peril is as low as could be normal the situation being what it is.

The Breast Cancer Society of Canada, Canada; American Cancer Society, USA; National Breast Cancer Foundation (NBCF) Australia; New Zealand Breast Cancer Foundation, New Zealand; European Society for Medical Oncology , EUSOMA - European Society of Breast Cancer Specialists, Italy; The Breast Cancer Research Foundation, USA; Japanese Breast Cancer Society, Japan; Irish Cancer Society, Ireland; Austrian Cancer Society, Austria, German Cancer Society, Germany; Swedish Cancer Society, Sweden; UK Oncology Nursing Society, UK; Naturopathic Cancer Society, USA

Track 4: Surgery in Breast Cancer

Medical procedure has dependably been the basic technique to expel the tumor in growth. It is the most polished treatment technique in malignancy. Now and again tests aren't done until the point when the moment that the whole Cancer is exhausted by either Breast-saving medical procedure (BCS) or Mastectomy. The bosom monitoring medical procedure is expulsion of the harm by saving the bosom however mastectomy is expelling the whole bosom by closing down the spreading of disease to different parts. Women going for BCS has good position of keeping the greater part of her bosom anyway she will in like manner require radiation. Women going for mastectomy at prior stages are less disposed to require radiation. In light of the kind of bosom tumor mastectomy may be the better decision for a couple of women. On the off chance that a liberal condition is destitute down, you will require no further treatment. Regardless, it is significant to discover from your master if the pleasing condition puts you at higher hazard for chest hurt later on and what sort of follow-up you may require. On the off chance that the conclusion is Cancer, there ought to be the ideal open entryway for you to find a few solutions concerning the ailment and to take a gander at treatment decisions with your threat mind social affair, mates, and family. It is regularly not indispensable to hustle into treatment. You may need to get a moment assessment before picking what treatment is best for you.

The Breast Cancer Society of Canada, Canada; American Cancer Society, USA; National Breast Cancer Foundation (NBCF) Australia; New Zealand Breast Cancer Foundation, New Zealand; European Society for Medical Oncology , EUSOMA - European Society of Breast Cancer Specialists, Italy; The Breast Cancer Research Foundation, USA; Japanese Breast Cancer Society, Japan; Irish Cancer Society, Ireland; Austrian Cancer Society, Austria, German Cancer Society, Germany; Swedish Cancer Society, Sweden; UK Oncology Nursing Society, UK; Naturopathic Cancer Society, USA

Track 5: Breast Cancer Treatment

Most ladies with bosom disease will have some kind of medical procedure to expel the tumor. Contingent upon the kind of bosom growth and how exceptional it is, you may require different sorts of treatment too, either previously or after medical procedure, or here and there both.Typically, treatment designs depend on the sort of bosom malignancy, its stage, and any extraordinary situations.The American Cancer Society likewise has projects and administrations – including rides to treatment, hotel, and that's just the beginning – to enable you to get past treatment.Your tumor mind group will be your first wellspring of data and support, however there are numerous spots you can get more help on the off chance that you require it. Doctor's facility or center based help administrations are an essential piece of your care. These might incorporate medical attendant or social work administrations, budgetary guide, wholesome exhortation, recovery, or profound help.

The Breast Cancer Society of Canada, Canada; American Cancer Society, USA; National Breast Cancer Foundation (NBCF) Australia; New Zealand Breast Cancer Foundation, New Zealand; European Society for Medical Oncology , EUSOMA - European Society of Breast Cancer Specialists, Italy; The Breast Cancer Research Foundation, USA; Japanese Breast Cancer Society, Japan; Irish Cancer Society, Ireland; Austrian Cancer Society, Austria, German Cancer Society, Germany; Swedish Cancer Society, Sweden; UK Oncology Nursing Society, UK; Naturopathic Cancer Society, USA

Track 6: Breast Cancer on Pregancy

If you develop breast cancer during pregnancy the treatment you are offered will depend on the type and extent of your breast cancer, the trimester of your pregnancy when the cancer is diagnosed and your individual circumstances.Effective treatment for breast cancer can be given during pregnancy without affecting the baby. You cannot pass cancer on to your baby and there is no evidence that having breast cancer during pregnancy affects your baby’s development in any way.Terminating the pregnancy isn’t usually recommended when breast cancer is diagnosed. Most women will be able to carry on with their pregnancy while having breast cancer treatment.There’s no evidence to suggest that a termination will improve the outcome for women diagnosed with breast cancer during pregnancy. However, termination may be discussed if chemotherapy is recommended during the first trimester.

The Breast Cancer Society of Canada, Canada; American Cancer Society, USA; National Breast Cancer Foundation (NBCF) Australia; New Zealand Breast Cancer Foundation, New Zealand; European Society for Medical Oncology , EUSOMA - European Society of Breast Cancer Specialists, Italy; The Breast Cancer Research Foundation, USA; Japanese Breast Cancer Society, Japan; Irish Cancer Society, Ireland; Austrian Cancer Society, Austria, German Cancer Society, Germany; Swedish Cancer Society, Sweden; UK Oncology Nursing Society, UK; Naturopathic Cancer Society, USA

Track 7: Gynecology | Infectious Diseases | Oncology

Contaminations in the female genitalia and the extra sex organs are regularly known as Gynecologic Infectious Diseases. While a portion of these ailments can be cured effectively by the use of anti-infection agents while others should be given careful consideration while curing them. A portion of the irresistible infections are Vulvovaginitis, Cervicitis, Pelvic Inflammatory Diseases and Sexually Transmitted Diseases. Gynecologic Oncology is a specific field that arrangements with growths relating to the female genitalia and conceptive framework. Ovarian malignancy, uterine disease, vaginal growth, cervical tumor and vulvar disease are each of the a piece of gynaecologic oncology. As indicated by the information gathered by The Society of Gynecologic Oncology 82,00 ladies in the United States were influenced by gynaecologic malignancy every year.

Related Conferences35th Annual Miami Breast Cancer Conference March 8-11, 2018, Fontainebleau Miami Beach,7th World Congress Breast Cancer May 10-11,2018 Frankfurt, Germany,8th World Congress Breast Cancer & Therapies, July 16-17,2018 Melbourne,Australia,7th World Congress on Breast Cancer Mat 25-26,2018,Radissson Hotel Fairport New York,USA,World Congress On Breast Cancer ,London,UK,June11,13,2018, Thriving Together: 2018 Conference on Metastatic Breast Cancer, April 20,2018,2nd  International Conference on Women Health And Breast Cancer, May 24-25, 2018 at Valencia, Spain, 3rd Global Insight Conference on Breast Cancer Jul 16 - 18, 2018, Valencia, Spain, The 28th Annual Interdisciplinary Breast Center ConferenceThe 28th Annual Interdisciplinary Breast Center Conference, 2018 Conference March 9-14, Paris Las Vegas, International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2018 San Diego, California, USA, Cancer Genetics Course 2018, 29 Jan 2017 - 01 Feb 2018 • London, United Kingdom.

Track 8: Assisted Reproductive Technology (ART)

The technology which is used to achieve pregnancy artificially is known as the assisted reproductive technology. Assisted reproductive technology includes procedures namely fertility medication, in vitro fertilization(IVF)  and surrogacy. ART is primarily used in treating infertility among couples. It belongs mainly to the field of reproductive endocrinology and infertility. ART includes many techniques such as intracytoplasmic sperm injection(ICSI), cryopreservation, transvaginal ovum retrival, embryo transfer, assisted zona hatching, autologous endometrial co-culture, zygote intrafallopian transfer, cytoplasmic transfer, egg donors, sperm donors, preimplantation genetic diagnosis, emryo splitting, GIFT, ZIFT, sex selection and surgical sperm retrival. All these methods are being widely used as problems of infertility are increasing at an alarming rate worldwide. While some of these methods are safe but majority of them are harmful to the fetus as the babies are born with some kind of birth defects or genetic defects.ART also carries the risk of heterotopic pregnancy. In IVF and ICSI babies are born with low birth weight, decreased expression of proteins in energy metabolism, visual impairment and cerebral palsy. ART procedures in the United States has doubled in the last 10years with the cost ranging from $2,000 to $30,000. ART procedures should be only performed after examing the medical condition of the couple. Many a times ART proves to be harmful to both the mother and child.

The Breast Cancer Society of Canada, Canada; American Cancer Society, USA; National Breast Cancer Foundation (NBCF) Australia; New Zealand Breast Cancer Foundation, New Zealand; European Society for Medical Oncology , EUSOMA - European Society of Breast Cancer Specialists, Italy; The Breast Cancer Research Foundation, USA; Japanese Breast Cancer Society, Japan; Irish Cancer Society, Ireland; Austrian Cancer Society, Austria, German Cancer Society, Germany; Swedish Cancer Society, Sweden; UK Oncology Nursing Society, UK; Naturopathic Cancer Society, USA

Track 9: Breast Imaging Dosimetry

Distinctive undertakings have been made to surmise a dose estimation that legitimately measures the imperativeness devoured by the radiosensitive tissue in the bosom. It is as of now understood that this radiosensitive tissue is the dynamic glandular tissue. A bit of the dosimetric measures that have been used as a piece of the past are skin-entrance dose, mid-bosom estimation and total imperativeness conceded to the breast.28,50 All of these estimations have insufficient assessed the estimations devoured by the tissue at peril. Today, ordinary glandular dose (AGD) is used as a measure of the estimation to the tissue at risk.50 However, an in-vivo estimation of the mean glandular estimations isn't down to earth.

The Breast Cancer Society of Canada, Canada; American Cancer Society, USA; National Breast Cancer Foundation (NBCF) Australia; New Zealand Breast Cancer Foundation, New Zealand; European Society for Medical Oncology , EUSOMA - European Society of Breast Cancer Specialists, Italy; The Breast Cancer Research Foundation, USA; Japanese Breast Cancer Society, Japan; Irish Cancer Society, Ireland; Austrian Cancer Society, Austria, German Cancer Society, Germany; Swedish Cancer Society, Sweden; UK Oncology Nursing Society, UK; Naturopathic Cancer Society, USA

Track 10: Genetics of Breast Cancer

Qualities related to tumor and hereditary qualities of those are accepted to be one of the explanation behind the death rate going from 5-10%. Ladies or moms who have been determined to have bosom malignancy before the age of 50 will probably pass on the qualities to their posterity's and can be influenced hereditarily all through the age. Qualities BRCA1 and BRCA2 are two of them related with the hereditary qualities of Breast Cancer. The danger of bosom tumor over the age of 80 and the death rate changes from 4-5%. Understanding the qualities is imperative with regards to genetic components causing bosom growth.

The Breast Cancer Society of Canada, Canada; American Cancer Society, USA; National Breast Cancer Foundation (NBCF) Australia; New Zealand Breast Cancer Foundation, New Zealand; European Society for Medical Oncology , EUSOMA - European Society of Breast Cancer Specialists, Italy; The Breast Cancer Research Foundation, USA; Japanese Breast Cancer Society, Japan; Irish Cancer Society, Ireland; Austrian Cancer Society, Austria, German Cancer Society, Germany; Swedish Cancer Society, Sweden; UK Oncology Nursing Society, UK; Naturopathic Cancer Society, USA

Track 11: Breast Cancer and New Innovations in Treatment

Microscope in a needle and Optical Elastography are the two new innovations in the field of breast cancer treatment. The Microscope in a needle technique uses medical imaging device and OCT (Optical Coherence Tomography) the innovation is in a developing stage and will be available in hospital in around five years. Optical Elastography can be said the advanced innovation in breast cancer where the finger tip device allows the surgeon to take high resolution images to see how tissue has moved, and even the cavity of the breast with microscopic accuracy. These innovations would bring drastic change in malignancy detection as well as treatment.

Related Conferences35th Annual Miami Breast Cancer Conference March 8-11, 2018, Fontainebleau Miami Beach,7th World Congress Breast Cancer May 10-11,2018 Frankfurt, Germany,8th World Congress Breast Cancer & Therapies, July 16-17,2018 Melbourne,Australia,7th World Congress on Breast Cancer Mat 25-26,2018,Radissson Hotel Fairport New York,USA,World Congress On Breast Cancer ,London,UK,June11,13,2018, Thriving Together: 2018 Conference on Metastatic Breast Cancer, April 20,2018,2nd  International Conference on Women Health And Breast Cancer, May 24-25, 2018 at Valencia, Spain, 3rd Global Insight Conference on Breast Cancer Jul 16 - 18, 2018, Valencia, Spain, The 28th Annual Interdisciplinary Breast Center ConferenceThe 28th Annual Interdisciplinary Breast Center Conference, 2018 Conference March 9-14, Paris Las Vegas, International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2018 San Diego, California, USA, Cancer Genetics Course 2018, 29 Jan 2017 - 01 Feb 2018 • London, United Kingdom.

Track 12: Rehabilitation of Breast Cancer

Breast Cancer and its treatment may influence your physical working and vitality. For example, numerous bosom tumor medications diminish estrogen in the body, which may diminish bone thickness. Exercise might be utilized to advance bone thickness and help bring down the danger of bosom tumor repeat. Exercise may likewise enable you to oversee treatment-related exhaustion, particularly amid radiation treatments.oncology restoration group is accessible to enable you to beat physical deficiencies, manufacture quality, diminish agony and battle fatigue.oncology recovery specialists are accessible to work with your careful oncologist to enable you to avoid or decrease lymphedema by utilizing waste systems, extending activities and back rubs. 

All through your Breast Cancer treatment, recovery specialists will be accessible to work with you and alternate individuals from your care group to help enhance your physical working and feeling of prosperity. 

Recovery group additionally gives an instructive part to enable you to comprehend the physical and mental advantages of physical rebuilding, and to help plan you and your family to continuing the program at home.

Related Conferences35th Annual Miami Breast Cancer Conference March 8-11, 2018, Fontainebleau Miami Beach,7th World Congress Breast Cancer May 10-11,2018 Frankfurt, Germany,8th World Congress Breast Cancer & Therapies, July 16-17,2018 Melbourne,Australia,7th World Congress on Breast Cancer Mat 25-26,2018,Radissson Hotel Fairport New York,USA,World Congress On Breast Cancer ,London,UK,June11,13,2018, Thriving Together: 2018 Conference on Metastatic Breast Cancer, April 20,2018,2nd  International Conference on Women Health And Breast Cancer, May 24-25, 2018 at Valencia, Spain, 3rd Global Insight Conference on Breast Cancer Jul 16 - 18, 2018, Valencia, Spain, The 28th Annual Interdisciplinary Breast Center ConferenceThe 28th Annual Interdisciplinary Breast Center Conference, 2018 Conference March 9-14, Paris Las Vegas, International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2018 San Diego, California, USA, Cancer Genetics Course 2018, 29 Jan 2017 - 01 Feb 2018 • London, United Kingdom.

The Breast Cancer Society of Canada, Canada; American Cancer Society, USA; National Breast Cancer Foundation (NBCF) Australia; New Zealand Breast Cancer Foundation, New Zealand; European Society for Medical Oncology , EUSOMA - European Society of Breast Cancer Specialists, Italy; The Breast Cancer Research Foundation, USA; Japanese Breast Cancer Society, Japan; Irish Cancer Society, Ireland; Austrian Cancer Society, Austria, German Cancer Society, Germany; Swedish Cancer Society, Sweden; UK Oncology Nursing Society, UK; Naturopathic Cancer Society, USA

Track 13: Abortion and Women Health:

Abortion is removing an embryo or fetus from t

he uterus before it can survive outside the uterus, which ends the pregnancy. An abortion which is intentional is called as induced abortion and which occurs spontaneously is called as Miscarriage. Induced abortion has negative impact on the women’s health. Due to the induced abortion women faces problems like lower fertility, more vulnerable to Sexual Transmitted Diseases, breast Cancer and mental health. Unsafe abortion sometimes results in death and serious complications.

Related Conferences35th Annual Miami Breast Cancer Conference March 8-11, 2018, Fontainebleau Miami Beach,7th World Congress Breast Cancer May 10-11,2018 Frankfurt, Germany,8th World Congress Breast Cancer & Therapies, July 16-17,2018 Melbourne,Australia,7th World Congress on Breast Cancer Mat 25-26,2018,Radissson Hotel Fairport New York,USA,World Congress On Breast Cancer ,London,UK,June11,13,2018, Thriving Together: 2018 Conference on Metastatic Breast Cancer, April 20,2018,2nd  International Conference on Women Health And Breast Cancer, May 24-25, 2018 at Valencia, Spain, 3rd Global Insight Conference on Breast Cancer Jul 16 - 18, 2018, Valencia, Spain, The 28th Annual Interdisciplinary Breast Center ConferenceThe 28th Annual Interdisciplinary Breast Center Conference, 2018 Conference March 9-14, Paris Las Vegas, International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2018 San Diego, California, USA, Cancer Genetics Course 2018, 29 Jan 2017 - 01 Feb 2018 • London, United Kingdom.

Track 14: Breast Cancer-Clinical Trials

  • Phase 1 (phase I) trials study whether a new treatment is safe to use over a range of doses. The treatment may be given to people with different types of cancers.
  • A phase 1 trial is mainly a drug safety study.
  • Phase 2 (phase II) trials study how well a treatment works for a certain cancer, such as breast cancer. These trials may include between 25 and 100 people.
  • After a drug (or other therapy) is found to be effective in treating breast cancer in a phase 2 trials, a phase 3 trial will study it further.
  • Phase 3 (phase III) trials study how well a new treatment (including surgical procedures) works compared to the standard treatment (standard of care).
  • Phase 4 (phase IV) trials study the long-term side effects of treatments or answer new questions about the treatment.

Market Analysis

Breast Cancer is the most well-known reason for death in ladies. Research on bosom malignancy is quickly advancing, yet the precise use of flow information to enhance understanding consideration remains an imposing test. Bosom Cancer Congress-2018 is the head occasion that unites a novel and International blend of specialists, Surgical and radiation oncologists, medicinal services experts, logical scientists and chiefs both from the scholarly community and industry over the globe to trade their insight, experience and research advancements in the finding and treatment for bosom growth.

Breast Cancer remedial and showcase examination surveys advertised and investigational items and blend regimens for the worldwide bosom disease therapeutics showcase. Division by tranquilize class is given, alongside supporting data, for example, clinical trial courses of events and comes about, recorded and anticipated dispatch timetables, and the study of disease transmission. Advertised and pipeline items are comprehensively portioned into hormonal treatment, directed treatment, chemotherapy, and different treatments of current worldwide intrigue.

Global Breast Cancer Therapeutics Market-Market Dynamics:

The key driving factors of the market are:

  • High incidence rate and prevalence worldwide
  • Increasing investments in R&D
  • Targeted drug delivery systems
  • Advancement in Cancer biology & pharmacology, promoting drug development

The factors restraining market growth are:

  • Stringent regulatory guidelines
  • Patent expiry of drugs

U.S. breast cancer therapeutics market accounted for largest business share in 2016 and is anticipated to grow substantially over the forecast period. Increased access to breast cancer detection, screening, diagnosis and treatment services will be the major growth rendering factor. Moreover, increasing adoption of therapy drug by patients will fuel regional business growth.

Transparency Market Research forecasts that the global breast cancer therapeutics market is expected to be worth US$16.21 bn by 2023 as compared to US$7.17 bn in 2014, surging at a CAGR of 8.4% between 2015 and 2023. The drastically changing reproductive patterns are also responsible for soaring revenue earnings of the breast cancer therapeutics market. The delayed childbearing age, reduced breastfeeding periods, intake of oral contraceptives, and resorting to hormonal therapies to solve other medical conditions is also contributing towards the growth of this market.

Study objectives global breast cancer market:

 

  • To provide the detail information about drivers and factors restraining the market growth
  • To provide the market growth map over the forecast period- 2017-2023
  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global breast cancer market
  • To provide the graphs and analyze the market on various factors like- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide the trends and opportunities in global breast cancer market
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to main countries.
  • To provide the overview of key players and their strategic profiles in the market and drawing a competitive landscape for the market.

The report for global breast cancer market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

 

Past Conference Report

Breast Cancer 2017

Breast Cancer 2017 Report

Gratitude’s to all of our honourable speakers, conference attendees and sponsors. Breast Cancer 2017 Conference was our best ever!

5th World Congress on Breast Cancer conference, hosted by the Conference Series LLC was held during June 15-17, 2017 London, UK at Holiday Inn London - Brentford Lock, London, UK with the theme “Pioneering Spirit of Enriching the Lives and Wellness of Women”. Magnanimous response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from the Scientists, Doctors, Professors, Oncologists, Radiologists, Pharmaceutical Industries, Healthcare Industries, Researchers and Students from the field of Breast Cancer, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Breast Cancer- Present Perspective
  • Breast Cancer Therapy, Prevention and Management
  • Surgery Choices for Breast Cancer
  • Rehabilitation/Survivorship After Treatment
  • Breast Cancer- Clinical Trails
  • Screening, Detecting, and Diagnosing Breast Cancer
  • Case studies
  • Male Breast Cancer
  • Breast Cancer Nursing
  • Personalized Medicine - A Redefined Treatment

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list included:

  • Lloyd Jenkins,  Budwig Center, Spain
  • Sarah Spiegel , Virginia Commonwealth University School of Medicine, USA
  • Valerijus Ostapenko, National Cancer Institute, Lithuania
  • Hiltrud Brauch,  Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Germany
  • Yun Gong, University of Texas-M D Anderson Cancer Center, USA 
  • Carole Verhoeven, Pantarhei Oncology BV, The Netherlands

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 19-20, 2018

Speaker Opportunity

Supported By

Journal of Womens Health, Issues and Care Journal of Cancer Science and Therapy Journal of Clinical and Experimental Oncology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner